| FAQ/Help |
| Calendar |
| Search |
| Today's Posts |
06-18-2020, 03:52 PM
|
#1 | |||
|
||||
|
Senior Member
|
This article from Medscape Today (June 5, 2020) indicates that the new oral disease-modifying treatments for MS haven't been as popular as they were expected to be--and Ocrevus seems to be the favorite DMT--"Newest oral DMTs haven't yet made a big impact in the MS world":
Newest Oral DMTs Haven't Yet Made a Big Impact in the MS World
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, since 12/16/20 |
|||
|
 Reply With Quote
|
|
06-20-2020, 06:01 PM
|
#2 | |||
|
||||
|
Elder
|
I tried two of them and the side effects were too harsh for me.
__________________
Wiz Turn Left at the next election. . RRMS DX 01/28/03 Started Copaxone again on 12/09/09 |
|||
|
|
Reply With Quote
|
|
06-20-2020, 07:22 PM
|
#3 | |||
|
||||
|
Senior Member
|
Just because it seems easier, you'd think people would prefer an oral treatment but when I think about making that choice, I'd stick with an injection or even an infusion over a pill--but I'm not sure why.
__________________
Repeal the law of gravity! MS diagnosed 1980. Type 2 diabetes, osteoarthritis. Avonex 2002-2005. Copaxone 6/4/07-5/15/10. Currently: Glatopa (generic Copaxone), 40mg 3 times/week, since 12/16/20 |
|||
|
|
Reply With Quote
|
| Reply |
| Thread Tools | |
| Display Modes | |
|
|
Similar Threads
|
||||
| Thread | Forum | |||
| Disease-modifying strategies for Parkinson's disease | Parkinson's Disease | |||
| Neuroprotective and disease-modifying effects of the ketogenic diet | Peripheral Neuropathy | |||
| Curetogether Survey: PN Treatments, popular vs effective | Peripheral Neuropathy | |||
| Disease modifying meds for Alzheimer in 3 years ? | Alzheimer's Disease | |||
Newest oral disease-modifying treatments haven't been as popular as expected
Linear Mode
